Stock Events

Stock Events

Vioquest Pharmaceuticals 

$0.003000
3
-$0.00-3.23% Monday 21:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.003
52W Low
0.000001
Volume
100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20AugExpected
Q3 2006
Q4 2006
Q1 2007
Q2 2007
Q3 2007
Q1 2008
Q2 2008
-0.63
-0.54
-0.46
-0.38
Expected EPS
N/A
Actual EPS
-0.375

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines across various therapeutic areas, directly competing with Vioquest's product lines.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines, similar to Vioquest Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of products in the healthcare field, competing in similar markets as Vioquest.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline plc specializes in the creation and marketing of pharmaceutical and healthcare products, including those in the same categories as Vioquest.
Novartis
NVS
Mkt Cap293.94B
Novartis AG operates globally, providing solutions in pharmaceuticals that directly compete with Vioquest's therapeutic areas.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Vioquest in specific drug categories.
AMGEN
AMGN
Mkt Cap196.12B
Amgen Inc. focuses on human therapeutics and operates in the same biotechnological sectors as Vioquest, making them direct competitors.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb Company, a global biopharmaceutical company, develops prescription drugs and biologics in several therapeutic areas, competing with Vioquest.
Lilly(Eli) &
LLY
Mkt Cap1.06T
Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of a range of pharmaceutical products, competing in the same space as Vioquest.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, similar to Vioquest.

About

VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome. The company's pipeline also features VQD-002, a nucleoside analog presently in Phase I clinical trials for cancer treatment. Another key compound is Lenocta, a small molecule designed to inhibit various protein tyrosine phosphatases, which is progressing through Phase IIa clinical studies for indications like melanoma, renal cell carcinoma, and other solid tumors. Beyond its therapeutic drug development, VioQuest Pharmaceuticals offers chiral products, specialized technology, and bespoke synthesis development services. These services are provided to pharmaceutical and fine chemical companies at different stages of their product lifecycles. The firm was established in 2000 and operates from its corporate headquarters in Basking Ridge, New Jersey.
Show more...
CEO
Mr. Mark D. Dacko
Employees
3
Country
United States
ISIN
US9276252023

Listings

OTC Link
US
VOQP

0 Comments

Share your thoughts

FAQ

What is Vioquest Pharmaceuticals stock price today?▼
The current price of VOQP is $0.00 USD — it has decreased by -3.23% in the past 24 hours. Watch Vioquest Pharmaceuticals stock price performance more closely on the chart.
What is Vioquest Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Vioquest Pharmaceuticals stocks are traded under the ticker VOQP.
What were Vioquest Pharmaceuticals earnings last quarter?▼
VOQP earnings for the last quarter are -0.38 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Vioquest Pharmaceuticals have?▼
As of July 22, 2026, the company has 3 employees.
In which sector is Vioquest Pharmaceuticals located?▼
Vioquest Pharmaceuticals operates in the Health & Wellness sector.
When did Vioquest Pharmaceuticals complete a stock split?▼
The last stock split for Vioquest Pharmaceuticals was on April 30, 2008 with a ratio of 1:10.
Where is Vioquest Pharmaceuticals headquartered?▼
Vioquest Pharmaceuticals is headquartered in Basking Ridge, United States.